Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: Mycophenolate versus azathioprine

Transplantation

Volumn 69, Issue 3, 2000, Pages 436-439

  Sanchez Fructuoso, Ana I ^a,b   Prats, Dolores ^a   Naranjo, Pablo ^a   Fernández Pérez, Cristina ^a   González, Ma Jesús ^a   Mariano, Alberto ^a   González, Jesús ^a   Figueredo, Ma Angeles ^a   Martin, Jesús Ma ^a   Paniagua, Vicente ^a   Fereres, Jose ^a   De La Concha, Emilio Gómez ^a   Barrientos, Alberto ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; CORTICOSTEROID; CREATININE; CYCLOSPORIN; INFLUENZA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 17744407739     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200002150-00023     Document Type: Article

References (11)

1. Mauch TJ, Bratton S, Myers T, Krane E, Gentry SR, Kashtan CE. Influenza-B virus infection in pediatric solid organ transplant recipients. Pediatrics 1994; 94: 225.
2. Apalsch AM, Green M, Ledesma-Medina J, Nour B, Wald ER. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995; 20(2): 394.
3. Grekas D, Alivanis P, Kiriazopoulou V, et al. Influenza vaccination on renal transplant patients is safe and serologically effective. J Clin Pharmacol Ther Toxicol 1993; 31(11): 553.
4. Briggs WA, Rozek RJ, Migdal SD. Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. Ann Intern Med 1980; 92: 471.
5. Carroll RNP, Marsh SD, O'Donoghue EPN, Breeze DC, Shackman R. Response to influenza vaccine by renal transplant patients. Br Med J 1974; 2: 701.
6. Mauch TJ, Crouch NA, Freese DK, Braulin EA, Dunn DL, Kashtan CE. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 1995; 127(6): 957.
7. Powers RD, Hayden FG, Samuelson JG, Gwaltney JM. Immune response of adults to sequential influenza vaccination. J Med Virol 1984; 14: 169.
8. Versluis DJ, Beyer WEP, Masurel N, Wenting GJ, Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 1986; 42(4): 376.
9. Smith KGC, Isbel NM, Catton MG, Leydon JA, Becker GJ, Walker RG. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998; 13(1): 160.
10. Meiklejohn G, Hoffman R, Graves P. Effectiveness of influenza vaccine when given during an outbreak of influenza A/H3N2 in a nursing home. J Am Geriatr Soc 1989; 37(5): 407.
11. Hibberd PL, Rubin RH. Approach to immunization in the immunosuppressed host. Infect Dis Clin North Am 1990; 4(1): 123.